KT&G seeks $200 mn acquisition of Nordic nicotine pouch maker
KT&G Corp. is in talks to acquire a leading nicotine pouch company in Northern Europe for about 300 billion won, or $200 million, investme...
KT&G to buy back shares, rejects Ginseng unit buyout offer
South Korean tobacco maker KT&G Corp. on Thursday unveiled a plan to buy back shares and pay dividends totaling 3.7 trillion won ($2.7 billion) ...
Flashlight Capital offers to buy KT&G’s ginseng business for $1.4 billion
Singapore-based investment management firm Flashlight Capital Partners Pte. (FCP) has offered to buy South Korean tobacco maker KT&G Corp.'s gin...
Huonslab eyes speedy anticancer drug delivery with new patent
South Korean biotech Huons Global Co. said on Tuesday that its research and development unit Huonslab has issued a domestic patent claiming a techno...
KGC enters Malaysian healty functional food market
Korea Ginseng Corp. (KGC), wholly owned by South Korean tobacco giant KT&G Corp., announced on June 13 that it sells its red ginseng brand Jung ...
Global quest to find modern elixirs enters new chapter
NEW YORK/ BOSTON – Longevity has long been the dream of humankind. China’s first emperor Qin Shi Huang was obsessed with finding magic e...
LG Chem to start phase 3 for head, neck cancer drug in US
South Korea’s LG Chem Ltd. announced on Wednesday that its US-based subsidiary Aveo Pharmaceuticals will start Phase 3 clinical trials for its...
MedPacto gets FDA OK for colorectal cancer drug clinical trial
South Korea's biotech company MedPacto Inc. announced on Tuesday that it has got approval from the US Food and Drug Administration (FDA) for its I...
KGC hawks red ginseng at top US expo for health functional food
Jung Kwan Jang, the flagship brand of Korea Ginseng Corp. (KGC), has been featured at North America’s leading expo for raw ingredients of heal...
Red ginseng proven to treat drug addiction: Research
It has been revealed that red ginseng significantly improves drug addiction and withdrawal symptoms caused by substance abuse. The research results ...
LG Display, LG Chem develop homegrown OLED material
South Korea’s LG Display Co. and LG Chem Ltd. have domestically produced a core material for organic light-emitting diode (OLED) that they pre...
S.Korea's Qurient, US National Cancer Institute to develop anti-cancer drug
South Korea's Qurient Co. announced on Monday that it signed a research and development agreement with the US government agency National Cancer Inst...
SK Biopharmaceuticals gets OK to sell epilepsy drug in Canada
South Korea's SK Biopharmaceuticals has received approval in Canada to sell its new epilepsy drug Cenobamate under the product name Xcopri. Having e...
KGC unifies BI of red ginseng brand as JUNG KWAN JANG
Korea Ginseng Corp. (KGC), wholly owned by South Korean tobacco giant KT&G Corp., will unify its red ginseng brand identity (BI) as JUNG KWAN JA...
KGC promotes S.Korean top red ginseng brand CheongKwanJang in China
Korea Ginseng Corp. (KGC), wholly owned by South Korean tobacco giant KT&G Corp. , announced on Thursday its participation in the "2023 TFWA Wor...
Oil from S.Korea’s red ginseng alleviates prostate enlargement: study
Oil from South Korea’s famous hongsam (red ginseng) can prevent enlargement of the prostate, according to a study. A joint research team ...
Korea Ginseng Corporation opens new R&D center in California
Korea Ginseng Corporation (KGC), a leading producer of Korean ginseng products, said on Wednesday that it has opened a new research and development ...
S.Korea's KGC to spur ginseng sales in China with state-run CR Group
Korea Ginseng Corp. (KGC), wholly owned by South Korean tobacco giant KT&G Corp., is set to accelerate sales of its ginseng products across Chin...
S.Korea’s KT&G engulfed in lawsuit against activist funds
The world’s fifth-largest tobacco maker KT&G’s battle against activist investors intensified as a group of funds sued the South Kore...
Celltrion's Truxima shows safety, efficacy in post-marketing study
South Korean biopharmaceutical company Celltrion Inc. reported on Wednesday that its biosimilar drug Truxima (rituximab), a generic version of Roche...
Red ginseng prevents flu, pneumonia: research
Studies have shown that South Korea's hongsam (red ginseng) is effective in preventing respiratory diseases such as the flu and pneumonia.The Korean...
KT&G refuses activist funds' call for ginseng biz spinoff
KT&G Corp., the world’s fifth-largest tobacco maker, on Thursday refused activist funds' requests to spin off and list its ginseng unit wh...
Medipost completes first dose of Cartistem in phase 3 clinical trials in Japan
South Korea's stem cell research company Medipost Co. said on Monday that it has completed the administration of Cartistem, a stem cell treatment fo...
LG Chem confirms diabetes drug Zemidapa's efficacy in phase 3 trials
LG Chem Ltd. announced in a disclosure on Monday that it had confirmed superior efficacy in phase 3 clinical trials for the combined administration ...
KT&G enlists Goldman Sachs to cope with shareholder activism
KT&G Corp., the world’s fifth-largest tobacco maker, appointed Goldman Sachs as an advisor to improve corporate governance after a Singapo...
Korea's premium pet food market sees rapid growth
Korea's pet food market is getting more sophisticated, with brands appearing whose products are even more expensive than food for humans despite hav...
KT&G taps top-tier law firm to defend itself against shareholder activism
KT&G Corp., the world’s fifth-largest tobacco maker, has appointed South Korea’s top-tier law firm Kim & Chang to take action ag...
Want to improve memory? Eat more ginseng
Consumption of ginseng and red ginseng (hongsam) can improve memory capacity and prevent high blood pressure, diabetes and muscle loss, according to...
Singapore PE firm proposes KT&G spin off ginseng biz
A Singaporean private equity firm has proposed a number of measures to KT&G Corp., the world’s fifth-largest tobacco maker, including a sp...
Korean bio firms look to pills, patches for people who fear needles
Getting shots of a drug or vaccine over a long period is not easy for many people.That's probably why global biopharmaceutical companies and biotech...
